Information  X 
Enter a valid email address

Alliance Pharma PLC Ord 1P (APH)

Related News

18-May-2022 01:41 PM

Alliance Pharma Chair Cook to depart in 2023, LeCouilliard to replace

Alliance Pharma PLC said on Wednesday Chair David Cook is to step down next year in line with ‘good corporate governance’. The Chippenham, England-based distributor of consumer healthcare brands and prescription medicines said Coo
25-Mar-2022 12:53 PM

IN BRIEF: Alliance Pharma buys ScarAway brand from Perrigo

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Says it acquires silicone-based scar treatment brand ScarAway from Perrigo Co PLC. Alliance Pharma also buys the rights to sell its s
22-Mar-2022 09:01 PM

EARNINGS UPDATES: MP Evans dividend outlook bright; ScS share buyback

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Sabre Insurance Group PLC - Surrey, England-based motor insurance underwriter - Gross written pr
21-Mar-2022 03:22 PM

IN BRIEF: Alliance Pharma in talks for acquisition of two US products

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Confirms that it is in talks with an unnamed third party for the acquisition of two products in the US. Should an acquisition take pl
20-Jan-2021 09:14 AM

Alliance Pharma sees underlying profit 'marginally' ahead of market expectations

Healthcare company Alliance Pharma said it expected underlying pre-tax profit to marginally top market expectations following 'strong' performance from its consumer healthcare brands. See-through revenue for 2020 was down 5% on the prior year
22-Sep-2020 09:32 AM

Alliance Pharma profit falls 96% in H1 on lower revenue, impairments

Alliance Pharma reported a slump in first-half profit owing to the impact of the pandemic, though the healthcare group said that it was now seeing signs of recovery. For the six months ended 30 June 2020, pre-tax profit fell 96% to £0.6m on-year
21-Jul-2020 09:49 AM

Alliance Pharma continues to bet on second-half recovery as revenue slips in H1

Healthcare group Alliance Pharma reported that first-half revenue was hurt by the COVID-19 pandemic, but continued to expect a further recovery in the second half of the year. For the six months ended 30 June 2020, revenue fell 7% to £65.3 on-ye
18-May-2020 01:52 PM

Alliance Pharma revenue down; sees confidence returning in China

Health care group Alliance Pharma said its revenue had fallen as expected due to the Covid-19 crisis. The company, however, had also been 'encouraged by the robustness of our product portfolio',' chief excutive Peter Butterfield said in AG
22-Jan-2020 09:43 AM

Alliance Pharma sees annual revenue rising 15%; profits in line

Healthcare group Alliance Pharma said it expected to report 15% growth in annual revenue and underlying profit in line with its expectations. Revenue for the year through December was seen rising to £135.6m, the company said. Excluding acquisitions
17-Jul-2019 09:36 AM

Alliance Pharma expects H1 revenues to rise 29%, led by consumer healthcare products

Alliance Pharma said it expected revenues to rise by more than fifth in the first half of the year amid growth from its consumer healthcare products. For the first half of 2019 revenues were expected to rise 29% to £70.3m from a year earlier and
23-May-2019 09:17 AM

Alliance Pharma continues to trade 'well' amid boost from International Star, local brands

Alliance Pharma it continued to trade 'well,' amid continued growth from its International Star brands and a 'solid' performance from its local brands. The company also confirmed that it had not benefit from any price increases in proc
01-May-2019 08:50 AM

Broker Forecast - Numis issues a broker note on Alliance Pharma PLC

Numis today upgrades its investment rating on Alliance Pharma PLC (LON:APH) to buy (from add). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Mar-2019 02:12 PM

Alliance Pharma profit falls 19% due to asset write-downs

Healthcare group Alliance Pharma booked a 19% drop in annual profit owing to asset write-downs, though its underlying performance improved. Pre-tax profit for the year through December fell to £22.8m, even as revenue rose 16% to £118.2m. Adj
19-Sep-2018 09:04 AM

Alliance Pharma profits weighed down by higher costs

Alliance Pharma reported Wednesday a marginal increase in first-half profit amid higher costs related to acquisition of Vamousse and continued investment in the company's International Star Brands. For the six months ended 30 June, profit before tax
25-Jul-2018 02:33 PM

Alliance Pharma sees revenue rising 10%, with slower rate of profit growth

Specialty pharmaceuticals group Alliance Pharma said it expected to post a 10% rise in first-half revenue, though the rate of profit growth would be lower due to spending on sales and marketing. Revenue for the six months through June was seen growing to
13-Jul-2018 10:10 AM

Broker Forecast - Numis issues a broker note on Alliance Pharma PLC

Numis today reaffirms its add investment rating on Alliance Pharma PLC (LON:APH) and raised its price target to 115p (from 99p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
07-Jun-2018 12:30 PM

Broker Forecast - Numis issues a broker note on Alliance Pharma PLC

Numis today downgrades its investment rating on Alliance Pharma PLC (LON:APH) to add (from buy) and raised its price target to 99p (from 88p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
09-May-2018 07:31 AM

Venture Life extends manufacturing contract with Alliance Pharma

Venture Life announced its manufacturing contract with Alliance Pharma has been extended until 2025. The company also secured additional business in excess of that currently undertaken for Alliance. Alliance is an international pharmaceutical company sp
17-Apr-2018 12:20 PM

Broker Forecast - Numis issues a broker note on Alliance Pharma PLC

Numis today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and raised its price target to 88p (from 80p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Jan-2018 07:57 AM

Acquisitions to boost Alliance Pharma prospects, says Hardman

Hardman Research has issued a report on Alliance Pharma. It says: 'Alliance Pharma is continuing with its buy-and-build strategy, having evolved through 35 acquisitions over a period of 20 years into a profitable, cash generative, specialty pharma b
28-Dec-2017 07:33 AM

Alliance Pharma completes Vamousse deal

Alliance Pharma's its wholly-owned subsidiary, Alliance Pharmaceuticals Ltd, has completed the acquisition of the worldwide rights to Vamousse from TyraTech. Alliance also announced the appointment of Amanda Sicvol as country manager for its newly
12-Dec-2017 08:20 AM

Broker Forecast - finnCap issues a broker note on Alliance Pharma PLC

finnCap today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and raised its price target to 70p (from 58p). Story provided by StockMarketWire.com...
04-Dec-2017 12:30 PM

Broker Forecast - Numis issues a broker note on Alliance Pharma PLC

Numis today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and set its price target at 71p. Story provided by StockMarketWire.com...
04-Dec-2017 07:11 AM

Alliance to acquire rights to Vamousse

Alliance Pharma's wholly owned subsidiary, Alliance Pharmaceuticals Limited, has agreed to acquire the worldwide rights to Vamousse from TyraTech Inc for an initial consideration of US$13.0m and deferred contingent consideration of up to US$4.5m.
01-Dec-2017 09:50 AM

Broker Forecast - Numis issues a broker note on Alliance Pharma PLC

Numis today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and set its price target at 66p. Story provided by StockMarketWire.com...

a d v e r t i s e m e n t